Worldwide Smoking Cessation and Nicotine De-Addiction Products Industry to 2028 - Featuring Pfizer, Cipla and McNeil Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Smoking Cessation and Nicotine De-Addiction Products Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's offering.

The report on the global smoking cessation and nicotine de-addiction products market provides qualitative and quantitative analysis for the period from 2022 to 2028.

The report predicts the global smoking cessation and nicotine de-addiction products market to grow with a CAGR of about 15% over the forecast period from 2022-2028. The study on smoking cessation and nicotine de-addiction products market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2022 to 2028.

The report on smoking cessation and nicotine de-addiction products market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global smoking cessation and nicotine de-addiction products market over the period of 2022 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global smoking cessation and nicotine de-addiction products market over the period of 2022 to 2028. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Segments Covered

The global smoking cessation and nicotine de-addiction products market is segmented on the basis of type, and distribution channel.

The Global Smoking Cessation and Nicotine De-addiction Products Market by Type

• E-cigarettes
• Drug Therapy
• Nicotine Replacement Therapies

The Global Smoking Cessation and Nicotine De-addiction Products Market by Distribution Channel

• Drug Store
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Company Profiles

The companies covered in the report include

• Takeda Pharmaceutical Co., Ltd.
• Pfizer, Inc.
• NJOY, Inc.
• Imperial Tobacco Company of India Limited.
• Cipla Ltd.
• Revolymer PLC
• Novartis International AG
• McNeil AB
• Glaxo Smith Kline PLC
• Others

Market Dynamics

Drivers

• Growing health consciousness among cigarette smokers
• Accessibility to a large range of nicotine replacement therapy (NRT) products

Restraints

• High cost associated with smoking cessation products

Opportunities

• New product innovations

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the smoking cessation and nicotine de-addiction products market.

2. Complete coverage of all the segments in the smoking cessation and nicotine de-addiction products market to analyze the trends, developments in the global market and forecast of market size up to 2028.

3. Comprehensive analysis of the companies operating in the global smoking cessation and nicotine de-addiction products market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

For more information about this report visit https://www.researchandmarkets.com/r/iodwda

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900